Journal article icon

Journal article

Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction

Abstract:
Desmoglein-2 mutations are detected in 5–10% of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). Endurance training accelerates the development of the ARVC phenotype, leading to earlier arrhythmic events. Homozygous Dsg2 mutant mice develop a severe ARVC-like phenotype. The phenotype of heterozygous mutant (Dsg2mt/wt) or haploinsufficient (Dsg20/wt) mice is still not well understood. To assess the effects of age and endurance swim training, we studied cardiac morphology and function in sedentary one-year-old Dsg2mt/wt and Dsg20/wt mice and in young Dsg2mt/wt mice exposed to endurance swim training. Cardiac structure was only occasionally affected in aged Dsg20/wt and Dsg2mt/wt mice manifesting as small fibrotic foci and displacement of Connexin 43. Endurance swim training increased the right ventricular (RV) diameter and decreased RV function in Dsg2mt/wt mice but not in wild types. Dsg2mt/wt hearts showed increased ventricular activation times and pacing-induced ventricular arrhythmia without obvious fibrosis or inflammation. Preload-reducing therapy during training prevented RV enlargement and alleviated the electrophysiological phenotype. Taken together, endurance swim training induced features of ARVC in young adult Dsg2mt/wt mice. Prolonged ventricular activation times in the hearts of trained Dsg2mt/wt mice are therefore a potential mechanism for increased arrhythmia risk. Preload-reducing therapy prevented training-induced ARVC phenotype pointing to beneficial treatment options in human patients.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3390/biomedicines12050985

Authors


More by this author
Role:
Author
ORCID:
0000-0002-9241-1733
More by this author
Role:
Author
ORCID:
0000-0003-1222-8830
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4019-1844
More by this author
Role:
Author
ORCID:
0000-0003-0675-7445
More by this author
Role:
Author
ORCID:
0000-0001-8906-5297


More from this funder
Funder identifier:
https://ror.org/031t5w623
More from this funder
Funder identifier:
https://ror.org/02wdwnk04


Publisher:
MDPI
Journal:
Biomedicines More from this journal
Volume:
12
Issue:
5
Article number:
985
Publication date:
2024-04-30
Acceptance date:
2024-04-23
DOI:
EISSN:
2227-9059

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP